Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality

Published:2020 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Sanese Paola,Fasano Candida,Buscemi Giacomo,Bottino Cinzia,Corbetta Silvia,Fabini Edoardo,Silvestri Valentina,Valentini Virginia,Disciglio Vittoria,Forte Giovanna,Lepore Signorile Martina,De Marco Katia,Bertora Stefania,Grossi Valentina,Porta Natale,Di Maio Valeria,Manoni Elisabetta,Giannelli Gianluigi,Bartolini Manuela,Del Rio Alberto,Caretti Giuseppina,Ottini Laura,Simone Cristiano

Publisher

Elsevier BV

Reference129 articles.

1. Current perspectives on CHEK2 mutations in breast cancer;P Apostolou;Breast Cancer,2017

2. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation;C J Bakkenist;Nature,2003

3. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence;N Blom;Proteomics,2004

4. C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis;C Bottino;Cancers (Basel),2015

5. FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices;K M Buchtel;J. Genet. Couns,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP